Abstract
Accumulation of senescent cells in vascular endothelium is known to contribute to vascular aging and increases the risk of developing cardiovascular diseases. The involvement of classical pathways such as p53/p21 and p16/pRB in cellular senescence are well described but there are emerging evidence supporting the increasingly important role of mammalian target of rapamycin (MTOR) as driver of cellular senescence via these pathways or other effector molecules. MicroRNAs (miRNAs) are a highly conserved group of small non-coding RNAs (18–25 nucleotides), instrumental in modulating the expression of target genes associated with various biological and cellular processes including cellular senescence. The inhibition of MTOR activity is predominantly linked to cellular senescence blunting and prolonged lifespan in model organisms. To date, known miRNAs regulating MTOR in endothelial cell senescence remain limited. Herein, this review discusses the roles of MTOR and MTOR-associated miRNAs in regulating endothelial cell senescence, including the crosstalk between MTOR Complex 1 (MTORC1) and cell cycle pathways and the emerging role of MTORC2 in cellular senescence. New insights on how MTOR and miRNAs coordinate underlying molecular mechanisms of endothelial senescence will provide deeper understanding and clarity to the complexity of the regulation of cellular senescence.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Afanasyeva EA et al (2011) MicroRNA miR-885-5p targets CDK2 and MCM5, activates p53 and inhibits proliferation and survival. Cell Death Differ 18:974–984. https://doi.org/10.1038/cdd.2010.164
Alimonti A et al (2010) A novel type of cellular senescence that can be enhanced in mouse models and human tumor xenografts to suppress prostate tumorigenesis. J Clin Invest 120:681–693. https://doi.org/10.1172/JCI40535
Anonymous (2017) A long and winding sTORy. Nat Cell Biol 19:1131. https://doi.org/10.1038/ncb3624
Astle MV et al (2012) AKT induces senescence in human cells via mTORC1 and p53 in the absence of DNA damage: implications for targeting mTOR during malignancy. Oncogene 31:1949–1962. https://doi.org/10.1038/onc.2011.394
Barilari M, Bonfils G, Treins C, Koka V, De Villeneuve D, Fabrega S, Pende M (2017) ZRF1 is a novel S6 kinase substrate that drives the senescence programme. EMBO J 36:736–750. https://doi.org/10.15252/embj.201694966
Bent EH, Gilbert LA, Hemann MT (2016) A senescence secretory switch mediated by PI3K/AKT/mTOR activation controls chemoprotective endothelial secretory responses. Genes Dev 30:1811–1821. https://doi.org/10.1101/gad.284851.116
Blagosklonny MV (2018) Rapamycin, proliferation and geroconversion to senescence. Cell Cycle 17:2655–2665. https://doi.org/10.1080/15384101.2018.1554781
Borodkina AV, Deryabin PI, Giukova AA, Nikolsky NN (2018) "Social Life" of senescent cells: what is SASP and why study it? Acta Nat 10:4–14
Burton DG, Krizhanovsky V (2014) Physiological and pathological consequences of cellular senescence. Cell Mol Life Sci 71:4373–4386. https://doi.org/10.1007/s00018-014-1691-3
Campisi J, Robert L (2014) Cell senescence: role in aging and age-related diseases. Interdiscip Top Gerontol 39:45–61. https://doi.org/10.1159/000358899
Castro AF, Rebhun JF, Clark GJ, Quilliam LA (2003) Rheb binds tuberous sclerosis complex 2 (TSC2) and promotes S6 kinase activation in a rapamycin- and farnesylation-dependent manner. J Biol Chem 278:32493–32496. https://doi.org/10.1074/jbc.C300226200
Chen K, Fan W, Wang X, Ke X, Wu G, Hu C (2012) MicroRNA-101 mediates the suppressive effect of laminar shear stress on mTOR expression in vascular endothelial cells. Biochem Biophys Res Commun 427:138–142. https://doi.org/10.1016/j.bbrc.2012.09.026
Chung HY et al (2009) Molecular inflammation: underpinnings of aging and age-related diseases. Ageing Res Rev 8:18–30. https://doi.org/10.1016/j.arr.2008.07.002
de Magalhaes JP, Passos JF (2018) Stress, cell senescence and organismal ageing. Mech Ageing Dev 170:2–9. https://doi.org/10.1016/j.mad.2017.07.001
Demaria M et al (2014) An essential role for senescent cells in optimal wound healing through secretion of PDGF-AA. Dev Cell 31:722–733. https://doi.org/10.1016/j.devcel.2014.11.012
Demidenko ZN, Zubova SG, Bukreeva EI, Pospelov VA, Pospelova TV, Blagosklonny MV (2009) Rapamycin decelerates cellular senescence. Cell Cycle 8:1888–1895. https://doi.org/10.4161/cc.8.12.8606
Dimri GP et al (1995) A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 92:9363–9367. https://doi.org/10.1073/pnas.92.20.9363
Donato AJ, Morgan RG, Walker AE, Lesniewski LA (2015) Cellular and molecular biology of aging endothelial cells. J Mol Cell Cardiol 89:122–135. https://doi.org/10.1016/j.yjmcc.2015.01.021
Donato AJ et al (2013) Life-long caloric restriction reduces oxidative stress and preserves nitric oxide bioavailability and function in arteries of old mice. Aging Cell 12:772–783. https://doi.org/10.1111/acel.12103
Dong F, Dong S, Liang Y, Wang K, Qin Y, Zhao X (2020) miR20b inhibits the senescence of human umbilical vein endothelial cells through regulating the Wnt/betacatenin pathway via the TXNIP/NLRP3 axis. Int J Mol Med 45:847–857. https://doi.org/10.3892/ijmm.2020.4457
Foreman KE, Tang J (2003) Molecular mechanisms of replicative senescence in endothelial cells. Exp Gerontol 38:1251–1257. https://doi.org/10.1016/j.exger.2003.09.005
Fridlyanskaya I, Alekseenko L, Nikolsky N (2015) Senescence as a general cellular response to stress: a mini-review. Exp Gerontol 72:124–128. https://doi.org/10.1016/j.exger.2015.09.021
Grivennikov SI, Greten FR, Karin M (2010) Immunity, inflammation, and cancer. Cell 140:883–899. https://doi.org/10.1016/j.cell.2010.01.025
Grundmann S et al (2011) MicroRNA-100 regulates neovascularization by suppression of mammalian target of rapamycin in endothelial and vascular smooth muscle cells. Circulation 123:999–1009. https://doi.org/10.1161/CIRCULATIONAHA.110.000323
Guo Y, Chao L, Chao J (2018) Kallistatin attenuates endothelial senescence by modulating Let-7g-mediated miR-34a-SIRT1-eNOS pathway. J Cell Mol Med 22:4387–4398. https://doi.org/10.1111/jcmm.13734
Harris TA, Yamakuchi M, Ferlito M, Mendell JT, Lowenstein CJ (2008) MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1. Proc Natl Acad Sci USA 105:1516–1521. https://doi.org/10.1073/pnas.0707493105
Hayflick L (1965) The mycoplasma (Pplo) species of man. Trans N Y Acad Sci 27:817–827. https://doi.org/10.1111/j.2164-0947.1965.tb02241.x
Heitman J, Movva NR, Hall MN (1991) Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast. Science 253:905–909. https://doi.org/10.1126/science.1715094
Herbig U, Jobling WA, Chen BP, Chen DJ, Sedivy JM (2004) Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21(CIP1), but not p16(INK4a). Mol Cell 14:501–513. https://doi.org/10.1016/s1097-2765(04)00256-4
Herranz N et al (2015) mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype. Nat Cell Biol 17:1205–1217. https://doi.org/10.1038/ncb3225
Hoffmann J, Haendeler J, Aicher A, Rossig L, Vasa M, Zeiher AM, Dimmeler S (2001) Aging enhances the sensitivity of endothelial cells toward apoptotic stimuli: important role of nitric oxide. Circ Res 89:709–715. https://doi.org/10.1161/hh2001.097796
Huynh J et al (2011) Age-related intimal stiffening enhances endothelial permeability and leukocyte transmigration. Sci Transl Med 3:112ra122. https://doi.org/10.1126/scitranslmed.3002761
Inoki K, Li Y, Xu T, Guan KL (2003) Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. Genes Dev 17:1829–1834. https://doi.org/10.1101/gad.1110003
Ito T, Yagi S, Yamakuchi M (2010) MicroRNA-34a regulation of endothelial senescence. Biochem Biophys Res Commun 398:735–740. https://doi.org/10.1016/j.bbrc.2010.07.012
Jacinto E, Loewith R, Schmidt A, Lin S, Ruegg MA, Hall A, Hall MN (2004) Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. Nat Cell Biol 6:1122–1128. https://doi.org/10.1038/ncb1183
Jazbutyte V et al (2013) MicroRNA-22 increases senescence and activates cardiac fibroblasts in the aging heart. Age 35:747–762. https://doi.org/10.1007/s11357-012-9407-9
Jiang F, Chen Q, Wang W, Ling Y, Yan Y, Xia P (2020) Hepatocyte-derived extracellular vesicles promote endothelial inflammation and atherogenesis via microRNA-1. J Hepatol 72:156–166. https://doi.org/10.1016/j.jhep.2019.09.014
Jong HL, Mustafa MR, Vanhoutte PM, AbuBakar S, Wong PF (2013) MicroRNA 299–3p modulates replicative senescence in endothelial cells. Physiol Genom 45:256–267. https://doi.org/10.1152/physiolgenomics.00071.2012
Julien LA, Carriere A, Moreau J, Roux PP (2010) mTORC1-activated S6K1 phosphorylates rictor on threonine 1135 and regulates mTORC2 signaling. Mol Cell Biol 30:908–921. https://doi.org/10.1128/MCB.00601-09
Khan SY et al (2017) Premature senescence of endothelial cells upon chronic exposure to TNFalpha can be prevented by N-acetyl cysteine and plumericin. Sci Rep 7:39501. https://doi.org/10.1038/srep39501
Khor ES, Wong PF (2018) Endothelial replicative senescence delayed by the inhibition of MTORC1 signaling involves MicroRNA-107. Int J Biochem Cell Biol 101:64–73. https://doi.org/10.1016/j.biocel.2018.05.016
Kolesnichenko M, Hong L, Liao R, Vogt PK, Sun P (2012) Attenuation of TORC1 signaling delays replicative and oncogenic RAS-induced senescence. Cell Cycle 11:2391–2401. https://doi.org/10.4161/cc.20683
Kolosova NG, Vitovtov AO, Muraleva NA, Akulov AE, Stefanova NA, Blagosklonny MV (2013) Rapamycin suppresses brain aging in senescence-accelerated OXYS rats. Aging 5:474–484. https://doi.org/10.18632/aging.100573
Krouwer VJ, Hekking LH, Langelaar-Makkinje M, Regan-Klapisz E, Post JA (2012) Endothelial cell senescence is associated with disrupted cell-cell junctions and increased monolayer permeability. Vasc Cell 4:12. https://doi.org/10.1186/2045-824X-4-12
Kuilman T et al (2008) Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network. Cell 133:1019–1031. https://doi.org/10.1016/j.cell.2008.03.039
Laberge RM et al (2015) MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation. Nat Cell Biol 17:1049–1061. https://doi.org/10.1038/ncb3195
Lal A et al (2008) p16(INK4a) translation suppressed by miR-24. PLoS ONE 3:e1864. https://doi.org/10.1371/journal.pone.0001864
Lee CH, Inoki K, Karbowniczek M, Petroulakis E, Sonenberg N, Henske EP, Guan KL (2007) Constitutive mTOR activation in TSC mutants sensitizes cells to energy starvation and genomic damage via p53. EMBO J 26:4812–4823. https://doi.org/10.1038/sj.emboj.7601900
Lee S, Choi E, Cha MJ, Park AJ, Yoon C, Hwang KC (2015) Impact of miRNAs on cardiovascular aging. J Geriatr Cardiol 12:569–574. https://doi.org/10.11909/j.issn.1671-5411.2015.05.011
Leontieva OV, Demidenko ZN, Blagosklonny MV (2015) Dual mTORC1/C2 inhibitors suppress cellular geroconversion (a senescence program). Oncotarget 6:23238–23248. https://doi.org/10.18632/oncotarget.4836
Lesniewski LA et al (2017) Dietary rapamycin supplementation reverses age-related vascular dysfunction and oxidative stress, while modulating nutrient-sensing, cell cycle, and senescence pathways. Aging Cell 16:17–26. https://doi.org/10.1111/acel.12524
Llanos S, Garcia-Pedrero JM, Morgado-Palacin L, Rodrigo JP, Serrano M (2016) Stabilization of p21 by mTORC1/4E-BP1 predicts clinical outcome of head and neck cancers. Nat Commun 7:10438. https://doi.org/10.1038/ncomms10438
Luo W et al (2018) Heme oxygenase-1 ameliorates oxidative stress-induced endothelial senescence via regulating endothelial nitric oxide synthase activation and coupling. Aging 10:1722–1744. https://doi.org/10.18632/aging.101506
Manvati S, Mangalhara KC, Kalaiarasan P, Srivastava N, Kumar B, Bamezai RN (2014) MiR-101 induces senescence and prevents apoptosis in the background of DNA damage in MCF7 cells. PLoS ONE 9:e111177. https://doi.org/10.1371/journal.pone.0111177
Marasa BS, Srikantan S, Martindale JL, Kim MM, Lee EK, Gorospe M, Abdelmohsen K (2010) MicroRNA profiling in human diploid fibroblasts uncovers miR-519 role in replicative senescence. Aging 2:333–343. https://doi.org/10.18632/aging.100159
McQuibban GA, Gong JH, Wong JP, Wallace JL, Clark-Lewis I, Overall CM (2002) Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo. Blood 100:1160–1167
Menghini R et al (2009) MicroRNA 217 modulates endothelial cell senescence via silent information regulator 1. Circulation 120:1524–1532. https://doi.org/10.1161/CIRCULATIONAHA.109.864629
Miller RA et al (2014) Rapamycin-mediated lifespan increase in mice is dose and sex dependent and metabolically distinct from dietary restriction. Aging Cell 13:468–477. https://doi.org/10.1111/acel.12194
Min EY, Kim IH, Lee J, Kim EY, Choi YH, Nam TJ (2014) The effects of fucodian on senescence are controlled by the p16INK4a-pRb and p14Arf-p53 pathways in hepatocellular carcinoma and hepatic cell lines. Int J Oncol 45:47–56. https://doi.org/10.3892/ijo.2014.2426
Minamino T, Miyauchi H, Yoshida T, Ishida Y, Yoshida H, Komuro I (2002) Endothelial cell senescence in human atherosclerosis: role of telomere in endothelial dysfunction. Circulation 105:1541–1544. https://doi.org/10.1161/01.cir.0000013836.85741.17
Mowla SN, Lam EW, Jat PS (2014) Cellular senescence and aging: the role of B-MYB. Aging Cell 13:773–779. https://doi.org/10.1111/acel.12242
Moyer CF, Sajuthi D, Tulli H, Williams JK (1991) Synthesis of IL-1 alpha and IL-1 beta by arterial cells in atherosclerosis. Am J Pathol 138:951–960
Munoz-Espin D et al (2013) Programmed cell senescence during mammalian embryonic development. Cell 155:1104–1118. https://doi.org/10.1016/j.cell.2013.10.019
Munoz-Espin D, Serrano M (2014) Cellular senescence: from physiology to pathology. Nat Rev Mol Cell Biol 15:482–496. https://doi.org/10.1038/nrm3823
Nacarelli T, Sell C (2017) Targeting metabolism in cellular senescence, a role for intervention. Mol Cell Endocrinol 455:83–92. https://doi.org/10.1016/j.mce.2016.08.049
Nakajima M, Hashimoto M, Wang F, Yamanaga K, Nakamura N, Uchida T, Yamanouchi K (1997) Aging decreases the production of PGI2 in rat aortic endothelial cells. Exp Gerontol 32:685–693. https://doi.org/10.1016/s0531-5565(97)00089-2
Nakamura K, Hongo A, Kodama J, Abarzua F, Nasu Y, Kumon H, Hiramatsu Y (2009) Expression of matriptase and clinical outcome of human endometrial cancer. Anticancer Res 29:1685–1690
Nakano M, Nakashima A, Nagano T, Ishikawa S, Kikkawa U, Kamada S (2013) Branched-chain amino acids enhance premature senescence through mammalian target of rapamycin complex I-mediated upregulation of p21 protein. PLoS ONE 8:e80411. https://doi.org/10.1371/journal.pone.0080411
Nam HY et al (2013) Radioresistant cancer cells can be conditioned to enter senescence by mTOR inhibition. Cancer Res 73:4267–4277. https://doi.org/10.1158/0008-5472.CAN-12-3516
Narita M et al (2011) Spatial coupling of mTOR and autophagy augments secretory phenotypes. Science 332:966–970. https://doi.org/10.1126/science.1205407
Noren Hooten N, Abdelmohsen K, Gorospe M, Ejiogu N, Zonderman AB, Evans MK (2010) microRNA expression patterns reveal differential expression of target genes with age. PLoS ONE 5:e10724. https://doi.org/10.1371/journal.pone.0010724
Ohtani N, Mann DJ, Hara E (2009) Cellular senescence: its role in tumor suppression and aging. Cancer Sci 100:792–797. https://doi.org/10.1111/j.1349-7006.2009.01123.x
Ono K, Kuwabara Y, Han J (2011) MicroRNAs and cardiovascular diseases. FEBS J 278:1619–1633. https://doi.org/10.1111/j.1742-4658.2011.08090.x
Ota H, Eto M, Ako J, Ogawa S, Iijima K, Akishita M, Ouchi Y (2009) Sirolimus and everolimus induce endothelial cellular senescence via sirtuin 1 down-regulation: therapeutic implication of cilostazol after drug-eluting stent implantation. J Am Coll Cardiol 53:2298–2305. https://doi.org/10.1016/j.jacc.2009.01.072
Pearson JD (2000) Normal endothelial cell function. Lupus 9:183–188. https://doi.org/10.1191/096120300678828299
Petroulakis E et al (2009) p53-dependent translational control of senescence and transformation via 4E-BPs. Cancer Cell 16:439–446. https://doi.org/10.1016/j.ccr.2009.09.025
Pospelova TV, Leontieva OV, Bykova TV, Zubova SG, Pospelov VA, Blagosklonny MV (2012) Suppression of replicative senescence by rapamycin in rodent embryonic cells. Cell Cycle 11:2402–2407. https://doi.org/10.4161/cc.20882
Rajapakse AG et al (2011) Hyperactive S6K1 mediates oxidative stress and endothelial dysfunction in aging: inhibition by resveratrol. PLoS ONE 6:e19237. https://doi.org/10.1371/journal.pone.0019237
Ramalingam P, Poulos M, Butler J (2016) Endothelial-specific Mtor signaling drives hematopoietic stem cell aging. Exp Hematol 44:S108–S108. https://doi.org/10.1016/j.exphem.2016.06.243
Ressler S, Bartkova J, Niederegger H, Bartek J, Scharffetter-Kochanek K, Jansen-Durr P, Wlaschek M (2006) p16INK4A is a robust in vivo biomarker of cellular aging in human skin. Aging Cell 5:379–389. https://doi.org/10.1111/j.1474-9726.2006.00231.x
Schnabl B, Purbeck CA, Choi YH, Hagedorn CH, Brenner D (2003) Replicative senescence of activated human hepatic stellate cells is accompanied by a pronounced inflammatory but less fibrogenic phenotype. Hepatology 37:653–664. https://doi.org/10.1053/jhep.2003.50097
Schober A et al (2014) MicroRNA-126-5p promotes endothelial proliferation and limits atherosclerosis by suppressing Dlk1. Nat Med 20:368–376. https://doi.org/10.1038/nm.3487
Selman C et al (2009) Ribosomal protein S6 kinase 1 signaling regulates mammalian life span. Science 326:140–144. https://doi.org/10.1126/science.1177221
Sen B, Xie Z, Case N, Thompson WR, Uzer G, Styner M, Rubin J (2014) mTORC2 regulates mechanically induced cytoskeletal reorganization and lineage selection in marrow-derived mesenchymal stem cells. J Bone Miner Res 29:78–89. https://doi.org/10.1002/jbmr.2031
Sherr CJ, Roberts JM (1999) CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 13:1501–1512. https://doi.org/10.1101/gad.13.12.1501
Su WJ et al (2018) miR-30 disrupts senescence and promotes cancer by targeting both p16(INK4A) and DNA damage pathways. Oncogene 37:5618–5632. https://doi.org/10.1038/s41388-018-0358-1
Sumpio BE, Riley JT, Dardik A (2002) Cells in focus: endothelial cell. Int J Biochem Cell Biol 34:1508–1512. https://doi.org/10.1016/s1357-2725(02)00075-4
Telgenhoff D, Shroot B (2005) Cellular senescence mechanisms in chronic wound healing. Cell Death Differ 12:695–698. https://doi.org/10.1038/sj.cdd.4401632
Tomimatsu K, Narita M (2015) Translating the effects of mTOR on secretory senescence. Nat Cell Biol 17:1230–1232. https://doi.org/10.1038/ncb3244
Tsai YC et al (2018) The interaction of miR-378i-Skp2 regulates cell senescence in diabetic. Nephropathy J Clin Med. https://doi.org/10.3390/jcm7120468
Tsuji-Tamura K, Ogawa M (2016) Inhibition of the PI3K-Akt and mTORC1 signaling pathways promotes the elongation of vascular endothelial cells. J Cell Sci 129:1165–1178. https://doi.org/10.1242/jcs.178434
Ungvari Z, Kaley G, de Cabo R, Sonntag WE, Csiszar A (2010) Mechanisms of vascular aging: new perspectives. J Gerontol A 65:1028–1041. https://doi.org/10.1093/gerona/glq113
Vellai T, Takacs-Vellai K, Zhang Y, Kovacs AL, Orosz L, Muller F (2003) Genetics: influence of TOR kinase on lifespan in C. elegans. Nature 426:620. https://doi.org/10.1038/426620a
Wan YZ et al (2014) SIRT1-mediated epigenetic downregulation of plasminogen activator inhibitor-1 prevents vascular endothelial replicative senescence. Aging Cell 13:890–899. https://doi.org/10.1111/acel.12247
Wang R et al (2017) Rapamycin inhibits the secretory phenotype of senescent cells by a Nrf2-independent mechanism. Aging Cell 16:564–574. https://doi.org/10.1111/acel.12587
Wang P, Liu XM, Ding L, Zhang XJ, Ma ZL (2018) mTOR signaling-related microRNAs and cancer involvement. J Cancer 9:667–673. https://doi.org/10.7150/jca.22119
Weichhart T, Saemann MD (2009) The multiple facets of mTOR in immunity. Trends Immunol 30:218–226. https://doi.org/10.1016/j.it.2009.02.002
Wong PF et al (2017) Deregulation of hsa-miR-20b expression in TNF-alpha-induced premature senescence of human pulmonary microvascular endothelial cells. Microvasc Res 114:26–33. https://doi.org/10.1016/j.mvr.2017.06.002
Wongjampa W, Ekalaksananan T, Chopjitt P, Chuerduangphui J, Kleebkaow P, Patarapadungkit N, Pientong C (2018) Suppression of miR-22, a tumor suppressor in cervical cancer, by human papillomavirus 16 E6 via a p53/miR-22/HDAC6 pathway. PLoS ONE 13:e0206644. https://doi.org/10.1371/journal.pone.0206644
Xiong YY, Yepuri G, Forbiteh M, Yu Y, Montani JP, Yang ZH, Ming XF (2014) ARG2 impairs endothelial autophagy through regulation of MTOR and PRKAA/AMPK signaling in advanced atherosclerosis. Autophagy 10:2223–2238. https://doi.org/10.4161/15548627.2014.981789
Xu D et al (2011) miR-22 represses cancer progression by inducing cellular senescence. J Cell Biol 193:409–424. https://doi.org/10.1083/jcb.201010100
Yamamoto H et al (2003) Association of trypsin expression with tumour progression and matrilysin expression in human colorectal cancer. J Pathol 199:176–184. https://doi.org/10.1002/path.1277
Yang HW et al (2018) mTORC2 facilitates endothelial cell senescence by suppressing Nrf2 expression via the Akt/GSK-3 beta/C/EBP alpha signaling pathway. Acta Pharmacol Sin 39:1837–1846. https://doi.org/10.1038/s41401-018-0079-6
Yang SJ, Mi XN, Chen Y, Feng CR, Hou ZH, Hui RT, Zhang WL (2018) MicroRNA-216a induces endothelial senescence and inflammation via Smad3/I kappa B alpha pathway. J Cell Mol Med 22:2739–2749. https://doi.org/10.1111/jcmm.13567
Yentrapalli R et al (2013) The PI3K/Akt/mTOR Pathway is implicated in the premature senescence of primary human endothelial cells exposed to chronic radiation. PLoS ONE. https://doi.org/10.1371/journal.pone.0070024
Yepuri G, Velagapudi S, Xiong YY, Rajapakse AG, Montani JP, Ming XF, Yang ZH (2012) Positive crosstalk between arginase-II and S6K1 in vascular endothelial inflammation and aging. Aging Cell 11:1005–1016. https://doi.org/10.1111/acel.12001
Zhao Y et al (2018) MiR-124 aggravates failing hearts by suppressing CD151-facilitated angiogenesis in heart. Oncotarget 9:14382–14396. https://doi.org/10.18632/oncotarget.24205
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Khor, ES., Wong, PF. The roles of MTOR and miRNAs in endothelial cell senescence. Biogerontology 21, 517–530 (2020). https://doi.org/10.1007/s10522-020-09876-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10522-020-09876-w